Jing Jing Cardona
Family Medicine · Jacksonville, FLNPI 1457331415
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,563 and has fallen 90.8% since, to $143 in 2025.
Across 157 payments — averaging $14.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$546
- Pfizer$219
- Novo Nordisk$166
- Takeda Pharmaceuticals U.S.A., Inc.$145
- Amgen$134
- Lilly USA, LLC$126
- plus $996 from 29 others
What the payments were for
- Food & beverage$2,327100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $546 |
| Pfizer | 24 | $219 |
| Novo Nordisk | 13 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $145 |
| Amgen | 7 | $134 |
| Lilly USA, LLC | 9 | $126 |
| Boehringer Ingelheim | 7 | $110 |
| GSK | 7 | $93 |
| Sanofi-aventis U.S. LLC | 4 | $67 |
| Boston Scientific | 1 | $59 |
| Merck | 4 | $54 |
| Teva Pharmaceuticals USA, Inc. | 4 | $54 |
| AbbVie(2 entities) | 4 | $50 |
| Astellas Pharma US Inc | 3 | $50 |
| Insulet Corporation | 2 | $45 |
| Metuchen Pharmaceuticals | 3 | $42 |
| Amarin Pharma, Inc. | 2 | $32 |
| IBSA Pharma Inc. | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Hikma Pharmaceuticals USA | 2 | $26 |
| Johnson & Johnson | 2 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Nalpropion Pharmaceuticals LLC | 2 | $24 |
| Antares Pharma, Inc. | 2 | $22 |
| Dexcom, Inc. | 1 | $17 |
| Dermira, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Vivus LLC | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Promius Pharma LLC | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
How this compares
$2,333 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 15 | $195 |
| Atorvastatin Calcium | 20 | $153 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Jacksonville
- Colin LacroixJacksonville$93K
- Sarfaraz DhanjiJacksonville$58K
- Victor MicolucciJacksonville$29K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.